Viral vector cGMP manufacturing

With years of experience producing cGMP viral vectors, we support a broad range of viral vector manufacturing platforms for gene and gene-modified cell therapies and vaccines including AAV, Adenovirus, Lentivirus, HSV, and Retrovirus. Our platforms are designed to support you from pre-clinical and human studies through to late phase and commercial programs.

Our capabilities include:

  Pre-clinical cGMP Late-Phase Clinical & Commercial
Suspension

50L

200L

50L

200L

4 x 200L

1000L

50L

200L

4 x 200L

1000L

2000L

Adherent

Up to 48 flatstock vessels

iCELLis® NANO

iCELLis® 500

Up to 48 flatstock vessels

iCELLis® 500

Up to 48 flatstock vessels

iCELLis® 500

View video to learn about challenges and opportunities of bringing viral vector products to market

Watch

Learn more about Patheon Viral Vector Services end-to-end capabilities.

Related Sites

Additional Resources